We are live on ! Find out more

iShares Global Healthcare ETF

IXJ

Market cap $4.2B

102.20 USD

-0.07

0.07%

At close Updated Sep 15, 2:28 PM EDT

1 day

-0.07%

5 days

0.21%

1 month

-0.08%

3 months

7.77%

6 months

7.26%

Year to date

4.57%

1 year

16.93%

5 years

17.42%

10 years

102.86%

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 42.1%

Neutral 42.1%

Negative 15.8%

The Motley Fool

State Street XLV vs. iShares IXJ: Here's How These Healthcare ETFs Stack Up for Investors

XLV has a significantly lower expense ratio of 0.08% compared to IXJ's 0.38%. IXJ provides broader exposure with 110 holdings across global markets, while XLV concentrates on 60 domestic S&P 500 stocks.

State Street XLV vs. iShares IXJ: Here's How These Healthcare ETFs Stack Up for Investors

The Motley Fool

IXJ vs XPH: Global Healthcare ETF or Pharma Focus?

iShares Global Healthcare ETF provides broad sector coverage with a higher dividend yield than State Street SPDR S&P Pharmaceuticals ETF. State Street SPDR S&P Pharmaceuticals ETF has delivered stronger total returns over the last year but experiences significantly higher maximum drawdowns.

IXJ vs XPH: Global Healthcare ETF or Pharma Focus?

KOSPI loses 7,000 in 24 hours as oil and yields hammer Korean stocks

South Korean stocks fell sharply on Thursday as Brent crude held above $100 a barrel, pushing the KOSPI back below the 7,000 mark just a day after it reclaimed the level for the first time in more than a month. The benchmark was down 1.28% at 6,961.23 by late morning in Seoul.

KOSPI loses 7,000 in 24 hours as oil and yields hammer Korean stocks

Zacks Investment Research

FDA Nods Lilly-Roche's Alzheimer's Blood Test: Healthcare ETFs to Track Now

FDA clearance of Lilly and Roche's Alzheimer's blood test highlights a growing diagnostics market and four healthcare ETFs to watch.

FDA Nods Lilly-Roche's Alzheimer's Blood Test: Healthcare ETFs to Track Now

The Motley Fool

Which Healthcare ETF Is the Better Buy: Vanguard's VHT or iShares' IXJ?

The Vanguard Health Care ETF (VHT) is significantly cheaper to own than the iShares Global Healthcare ETF (IXJ). IXJ offers exposure to international companies, while VHT focuses more heavily on the U.S. market.

Which Healthcare ETF Is the Better Buy: Vanguard's VHT or iShares' IXJ?

The Motley Fool

iShares Global Healthcare ETF vs State Street SPDR Biotech ETF. Which Healthcare-Focused Fund Will Bring You Profits in 2026 and Beyond?

iShares Global Healthcare ETF offers a 1.4% dividend yield and lower price volatility than State Street SPDR S&P Biotech ETF. State Street SPDR S&P Biotech ETF focuses on U.S. biotechnology, resulting in a higher 1-year total return of 80.2% but a significantly deeper maximum drawdown.

iShares Global Healthcare ETF vs State Street SPDR Biotech ETF. Which Healthcare-Focused Fund Will Bring You Profits in 2026 and Beyond?

The Motley Fool

iShares Global Healthcare ETF vs VanEck Biotech ETF: Which ETF Is Better for Profiting With Healthcare in 2026?

iShares Global Healthcare ETF provides broader diversification with 110 holdings compared to 25 positions in VanEck Biotech ETF VanEck Biotech ETF delivered a 30.8% 1-year total return but has experienced a 39.9% historical maximum drawdown iShares Global Healthcare ETF offers a 1.5% trailing-12-month dividend yield and a longer history since its 2001 launch

iShares Global Healthcare ETF vs VanEck Biotech ETF: Which ETF Is Better for Profiting With Healthcare in 2026?

The Motley Fool

Which iShares Healthcare ETF Is the Better Buy: Diversified IXJ or Biotech-Focused IBB?

iShares Global Healthcare ETF provides lower-cost exposure to the broader medical sector than iShares Biotechnology ETF. iShares Biotechnology ETF has delivered higher 1-year total returns but with significantly greater price volatility.

Which iShares Healthcare ETF Is the Better Buy: Diversified IXJ or Biotech-Focused IBB?

The Motley Fool

Concentrated Pharma Exposure or Broader Global Healthcare? PPH vs. IXJ

The iShares Global Healthcare ETF provides broader exposure with 110 holdings across various sub-sectors compared to the 26 positions in the VanEck Pharmaceutical ETF The VanEck Pharmaceutical ETF features a lower expense ratio of 0.36% and a higher trailing dividend yield of 2.00% While the iShares Global Healthcare ETF has experienced lower historical drawdowns, the VanEck Pharmaceutical ETF has delivered higher total returns over the last five years

Concentrated Pharma Exposure or Broader Global Healthcare? PPH vs. IXJ

The Motley Fool

PINK vs. IXJ: Which Health Care ETF Is the Better Buy for Investors?

The iShares Global Healthcare ETF (IXJ) charges a lower expense ratio and pays a higher dividend yield than the Simplify Health Care ETF (PINK). PINK has delivered stronger one-year and three-year returns than IXJ.

PINK vs. IXJ: Which Health Care ETF Is the Better Buy for Investors?

See News Rankings

Price charts implemented using Lightweight Charts™